Strategies & Technologies Driving Drug Discovery to Market
Subscribe to Drug Discovery & Development All
View Sample

FREE Email Newsletter

DDD Update

Daily news and top headlines for drug research professionals

Nanoantenna Camera

May 24, 2011 11:07 am | Product Releases | Comments

Nanoscale antennas hold out the promise of higher resolution optical imaging of nano objects, including proteins and DNA molecules, and converting solar energy into electricity at very high efficiencies.


Telephoto Lens

May 24, 2011 11:00 am | Product Releases | Comments

The introduction of a telephoto lens for Insitec laser diffraction process systems from Malvern Instruments enables the on-line measurement of larger particles.


Daiichi Sankyo Launches New Vaccine

May 24, 2011 10:45 am | News | Comments

Daiichi Sankyo Company, Limited launched its measles and rubella vaccine, Kitasato Daiichi Sankyo (freeze-dried live attenuated measles and rubella combined vaccine), in Japan.


FDA Clears Immunoassay System

May 24, 2011 10:42 am | News | Comments

Siemens Healthcare Diagnostics announces that it has received FDA clearance to market its IMMULITE 2000 XPi Immunoassay System in the United States.


Information Overload in Drug Side Effect Labeling

May 24, 2011 10:39 am | News | Comments

The lists of potential side effects that accompany prescription drugs have ballooned in size, averaging 70 reactions per drug, a number that can overwhelm physicians trying to select suitable treatments for their patients.


Accelrys Buys Contur Software

May 24, 2011 10:33 am | News | Comments

Accelrys, Inc., a leading scientific enterprise R&D software and services company, announced that its subsidiary, Accelrys Software Inc., has acquired privately-held Contur Software AB.


Valeant to Acquire AB Sanitas for $441M

May 24, 2011 10:28 am | News | Comments

Canadian drugmaker Valeant Pharmaceuticals International Inc. said it will acquire Lithuanian specialty pharmaceutical company AB Sanitas in a two-stage deal worth $441.3 million in cash.


Rare Natural Product Has Potent Pain-Killing Properties

May 24, 2011 8:22 am | News | Comments

Scientists have synthesized of a rare natural product isolated from the bark of a plant used in traditional medicine, an advance that may lead to alternatives to narcotic pain treatments.


Tribenzor Proves Effective Across Subgroups

May 24, 2011 8:15 am | News | Comments

Data evaluating the long-term efficacy and safety of Tribenzor (olmesartan medoxomil, amlodipine besylate, plus hydrochlorothiazide) in patients with hypertension aged 65 years and older showed that the triple therapy was well-tolerated and effective in maintaining the blood pressure reductions, regardless of age, race, or diabetes status.


Ontario Institute Invests in Research Firms

May 24, 2011 8:12 am | News | Comments

The Ontario Institute for Cancer Research (OICR) reported investments in three new Ontario companies aimed at bringing promising anticancer technologies to market.


Roche Honors Next Generation of Chemists

May 24, 2011 8:09 am | News | Comments

Roche honored 12 doctoral students and two professors with the company’s Excellence in Chemistry Award for research accomplishments in the field of organic chemistry.


BioCritica Inc. Formed

May 24, 2011 8:04 am | News | Comments

Eli Lilly and Company has signed agreements with Care Capital and NovaQuest Capital to establish BioCritica Inc., a   privately-held biotechnology company.


GenKyoTex Raises Funds to Develop NOX Enzyme Inhibitors

May 24, 2011 8:04 am | News | Comments

GenKyoTex has raised CHF18 million ($20.4 million), which will be used for the clinical development of the lead compound GKT137831 for the treatment of diabetic nephropathy.


New Bone Production

May 24, 2011 7:41 am | News | Comments

A study by researchers at Children’s Hospital Boston and collaborators has provided new insight into how bone cells produce new bone in response to mechanical stresses, such as exercise.


Natural Product Has Potent Pain-Killing Properties

May 24, 2011 7:29 am | News | Comments

Scientists from the Scripps Research Institute have synthesized of a rare natural product isolated from the bark of a plant widely employed in traditional medicine. This advance may provide the scientific foundation to develop an effective alternative to commonly prescribed narcotic pain treatments.



You may login with either your assigned username or your e-mail address.
The password field is case sensitive.